Megan Redshaw

Most cases were mild and primarily affected older adults over 75 years old.

Children come to rely on digital devices for emotional regulation instead of developing internal self-regulatory skills.

Tirzepatide, an antidiabetic and weight-loss medication marketed as Mounjaro and Zepbound, may reduce obesity, an underlying factor in sleep apnea.

Recreational use of lysergic acid diethylamide was linked to 1.6 to 1.7 times higher risk of severe psychological distress following job loss.

Early treatment with higher doses of the SSRI fluvoxamine may reduce COVID-19 clinical deterioration, mortality, and long-COVID complications.

Congress more than three years ago allocated $1.6 billion to the NIH to define, understand, and treat long COVID—and there’s largely nothing to show for it.

The risk-benefit ratio was deemed ‘acceptable’ even though more adverse events, including deaths, occurred in the drug treatment group.

A recent study found infants exposed to COVID-19 in utero scored lower in communication, gross motor, fine motor, problem-solving, and personal-social domains.

FDA advisors cited concerns over clinical data, selection and expectation bias, and the safety risks of MDMA.

A review in the BMJ found the largest reductions in depression with dance and intense exercise.

Most cases were mild and primarily affected older adults over 75 years old.

Children come to rely on digital devices for emotional regulation instead of developing internal self-regulatory skills.

Tirzepatide, an antidiabetic and weight-loss medication marketed as Mounjaro and Zepbound, may reduce obesity, an underlying factor in sleep apnea.

Recreational use of lysergic acid diethylamide was linked to 1.6 to 1.7 times higher risk of severe psychological distress following job loss.

Early treatment with higher doses of the SSRI fluvoxamine may reduce COVID-19 clinical deterioration, mortality, and long-COVID complications.

Congress more than three years ago allocated $1.6 billion to the NIH to define, understand, and treat long COVID—and there’s largely nothing to show for it.

The risk-benefit ratio was deemed ‘acceptable’ even though more adverse events, including deaths, occurred in the drug treatment group.

A recent study found infants exposed to COVID-19 in utero scored lower in communication, gross motor, fine motor, problem-solving, and personal-social domains.

FDA advisors cited concerns over clinical data, selection and expectation bias, and the safety risks of MDMA.

A review in the BMJ found the largest reductions in depression with dance and intense exercise.